{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:11:46Z","timestamp":1787155906663,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-01228-5","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T10:01:46Z","timestamp":1699092106000},"page":"4835-4859","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A systematic review regarding the prevalence of malignancy in patients with the hyper-IgE syndrome"],"prefix":"10.1007","volume":"23","author":[{"given":"Tayebeh","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosein","family":"Rafiemanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouria","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matineh","family":"Nirouei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Tavakol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,4]]},"reference":[{"issue":"7445","key":"1228_CR1","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0140-6736(66)90119-X","volume":"287","author":"S Davis","year":"1966","unstructured":"Davis S, Schaller J, Wedgwood R, Harvard M. Job\u2019s syndrome: recurrent,\" cold\", staphylococcal abscesses. The Lancet. 1966;287(7445):1013\u20135.","journal-title":"The Lancet"},{"key":"1228_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4069","volume":"14","author":"PF Yong","year":"2012","unstructured":"Yong PF, Freeman AF, Engelhardt KR, Holland S, Puck JM, Grimbacher B. An update on the hyper-IgE syndromes. Arthritis Res Ther. 2012;14:1\u201310.","journal-title":"Arthritis Res Ther"},{"key":"1228_CR3","doi-asserted-by":"publisher","first-page":"626593","DOI":"10.3389\/fimmu.2021.626593","volume":"12","author":"B Saikia","year":"2021","unstructured":"Saikia B, Rawat A, Minz RW, Suri D, Pandiarajan V, Jindal A, et al. Clinical profile of hyper-IgE syndrome in India. Front Immunol. 2021;12:626593.","journal-title":"Front Immunol"},{"issue":"1","key":"1228_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/archdermatol.2011.262","volume":"148","author":"EY Chu","year":"2012","unstructured":"Chu EY, Freeman AF, Jing H, Cowen EW, Davis J, Su HC, et al. Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol. 2012;148(1):79\u201384.","journal-title":"Arch Dermatol"},{"key":"1228_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.108988","volume":"237","author":"A Gharehzadehshirazi","year":"2022","unstructured":"Gharehzadehshirazi A, Amini A, Rezaei N. Hyper IgE syndromes: a clinical approach. Clin Immunol. 2022;237: 108988.","journal-title":"Clin Immunol"},{"issue":"7","key":"1228_CR6","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1007\/s10875-022-01352-z","volume":"42","author":"A Bousfiha","year":"2022","unstructured":"Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42(7):1508\u201320.","journal-title":"J Clin Immunol"},{"issue":"4","key":"1228_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.alit.2021.07.007","volume":"70","author":"Y Minegishi","year":"2021","unstructured":"Minegishi Y. Hyper-IgE syndrome, 2021 update. Allergol Int. 2021;70(4):407\u201314.","journal-title":"Allergol Int"},{"issue":"3","key":"1228_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10875-021-01196-z","volume":"42","author":"A Winslow","year":"2022","unstructured":"Winslow A, Jalazo ER, Evans A, Winstead M, Moran T. A de novo cause of PGM3 deficiency treated with hematopoietic stem cell transplantation. J Clin Immunol. 2022;42(3):691\u20134.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1228_CR9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.0105-2896.2005.00228.x","volume":"203","author":"B Grimbacher","year":"2005","unstructured":"Grimbacher B, Holland SM, Puck JM. Hyper-IgE syndromes. Immunol Rev. 2005;203(1):244\u201350.","journal-title":"Immunol Rev"},{"key":"1228_CR10","doi-asserted-by":"crossref","unstructured":"Ravichandran N, Uppuluri R, Swaminathan VV, Ramanan KM, Meena S, Varla H, et al. Management of peripheral T-cell lymphoma in children and adolescents including STAT 3 mutation hyper-IgE syndrome: one size does not fit all. J of Pediatr Hematol\/Oncol. 2022;44(4):e849\u2013e54.","DOI":"10.1097\/MPH.0000000000002364"},{"key":"1228_CR11","doi-asserted-by":"crossref","unstructured":"Al Shekaili L, Sheikh F, Al Gazlan S, Al Dhekri H, Al Mousa H, Al Ghonaium A, et al. Novel mutation in DOCK8- HIES with severe phenotype and successful transplantation. Clin Immunol. 2017;178:39\u201344.","DOI":"10.1016\/j.clim.2016.08.002"},{"issue":"3","key":"1228_CR12","first-page":"319","volume":"170","author":"B Grimbacher","year":"1999","unstructured":"Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. Hyper-IgE syndrome with recurrent infections\u2014an autosomal dominant multisystem disorder. N Engl J Med. 1999;170(3):319\u2013333.","journal-title":"N Engl J Med"},{"issue":"10","key":"1228_CR13","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1080\/00365540600740470","volume":"38","author":"M Moin","year":"2006","unstructured":"Moin M, Farhoudi A, Movahedi M, Rezaei N, Pourpak Z, Yeganeh M, et al. The clinical and laboratory survey of Iranian patients with hyper-IgE syndrome. Scand J Infect Dis. 2006;38(10):898\u2013903.","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"1228_CR14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.molimm.2008.07.001","volume":"46","author":"H Jiao","year":"2008","unstructured":"Jiao H, T\u00f3th B, Erd\u0151s M, Fransson I, R\u00e1k\u00f3czi \u00c9, Balogh I, et al. Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups. Mol Immunol. 2008;46(1):202\u20136.","journal-title":"Mol Immunol"},{"issue":"6","key":"1228_CR15","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jaci.2009.10.038","volume":"124","author":"KR Engelhardt","year":"2009","unstructured":"Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124(6):1289-302. e4.","journal-title":"J Allergy Clin Immunol"},{"issue":"21","key":"1228_CR16","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1056\/NEJMoa0905506","volume":"361","author":"Q Zhang","year":"2009","unstructured":"Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009;361(21):2046\u201355.","journal-title":"N Engl J Med"},{"issue":"4","key":"1228_CR17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","volume":"91","author":"M-O Chandesris","year":"2012","unstructured":"Chandesris M-O, Melki I, Natividad A, Puel A, Fieschi C, Yun L, et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine. 2012;91(4):e1\u201319.","journal-title":"Medicine"},{"issue":"3","key":"1228_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.clim.2012.03.002","volume":"143","author":"W Al-Herz","year":"2012","unstructured":"Al-Herz W, Ragupathy R, Massaad MJ, Nanda A, Engelhardt KR, Grimbacher B, et al. Clinical, immunologic and genetic profiles of DOCK8-deficient patients in Kuwait. Clin Immunol. 2012;143(3):266\u201372.","journal-title":"Clin Immunol"},{"key":"1228_CR19","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s10875-012-9664-5","volume":"32","author":"O Sanal","year":"2012","unstructured":"Sanal O, Jing H, Ozgur T, Ayvaz D, Strauss-Albee DM, Ersoy-Evans S, et al. Additional diverse findings expand the clinical presentation of DOCK8 deficiency. J Clin Immunol. 2012;32:698\u2013708.","journal-title":"J Clin Immunol"},{"key":"1228_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10875-012-9769-x","volume":"33","author":"Z Alsum","year":"2013","unstructured":"Alsum Z, Hawwari A, Alsmadi O, Al-Hissi S, Borrero E, Abu-staiteh A, et al. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty five patients. J Clin Immunol. 2013;33:55\u201367.","journal-title":"J Clin Immunol"},{"key":"1228_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10875-014-9988-4","volume":"34","author":"O Wolach","year":"2014","unstructured":"Wolach O, Kuijpers T, Ben-Ari J, Gavrieli R, Feinstein-Goren N, Alders M, et al. Variable clinical expressivity of STAT3 mutation in hyperimmunoglobulin E syndrome: genetic and clinical studies of six patients. J Clin Immunol. 2014;34:163\u201370.","journal-title":"J Clin Immunol"},{"key":"1228_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10875-014-0126-0","volume":"35","author":"SE Aydin","year":"2015","unstructured":"Aydin SE, Kilic SS, Aytekin C, Kumar A, Porras O, Kainulainen L, et al. DOCK8 deficiency: clinical and immunological phenotype and treatment options-a review of 136 patients. J Clin Immunol. 2015;35:189\u201398.","journal-title":"J Clin Immunol"},{"issue":"2","key":"1228_CR23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jaci.2014.12.1945","volume":"136","author":"KR Engelhardt","year":"2015","unstructured":"Engelhardt KR, Gertz ME, Keles S, Sch\u00e4ffer AA, Sigmund EC, Glocker C, et al. The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol. 2015;136(2):402\u201312.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1228_CR24","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.jaci.2017.06.049","volume":"141","author":"H Abolhassani","year":"2018","unstructured":"Abolhassani H, Chou J, Bainter W, Platt CD, Tavassoli M, Momen T, et al. Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency. J Allergy Clin Immunol. 2018;141(4):1450\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1228_CR25","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jaip.2017.06.041","volume":"6","author":"Y Gernez","year":"2018","unstructured":"Gernez Y, Freeman AF, Holland SM, Garabedian E, Patel NC, Puck JM, et al. Autosomal dominant hyper-IgE syndrome in the USIDNET registry. J Allergy Clin Immunol Pract. 2018;6(3):996\u20131001.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"1228_CR26","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/all.13610","volume":"74","author":"M Jacob","year":"2019","unstructured":"Jacob M, Bin Khalaf D, Alhissi S, Arnout R, Alsaud B, Al-Mousa H, et al. Quantitative profiling of cytokines and chemokines in DOCK 8-deficient and atopic dermatitis patients. Allergy. 2019;74(2):370\u20139.","journal-title":"Allergy"},{"issue":"4","key":"1228_CR27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/pai.13043","volume":"30","author":"M Tavassoli","year":"2012","unstructured":"Tavassoli M, Abolhassani H, Yazdani R, Ghadami M, Azizi G, Abdolrahim Poor Heravi S, et al. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: a long\u2010term follow\u2010up and genetic analysis. Pediatric Allergy Immunol 30(4):469\u201378","journal-title":"Pediatric Allergy Immunol"},{"key":"1228_CR28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fped.2019.00232","volume":"7","author":"M Maffeis","year":"2019","unstructured":"Maffeis M, Notarangelo LD, Schumacher RF, Soncini E, Soresina A, Lanfranchi A, et al. Primary immunodeficiencies and oncological risk: the experience of the Children\u2019s Hospital of Brescia. Front Pediatr. 2019;7:232.","journal-title":"Front Pediatr"},{"key":"1228_CR29","doi-asserted-by":"publisher","first-page":"108645","DOI":"10.1016\/j.clim.2020.108645","volume":"223","author":"N Kasap","year":"2021","unstructured":"Kasap N, Celik V, Isik S, Cennetoglu P, Kiykim A, Eltan SB, et al. A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis. Clin Immunol. 2021;223:108645.","journal-title":"Clin Immunol"},{"issue":"8","key":"1228_CR30","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1007\/s10875-021-01086-4","volume":"41","author":"N Frede","year":"2021","unstructured":"Frede N, Rojas-Restrepo J, Caballero Garcia de Oteyza A, Buchta M, H\u00fcbscher K, G\u00e1mez-D\u00edaz L, et al. Genetic analysis of a cohort of 275 patients with hyper-IgE syndromes and\/or chronic mucocutaneous candidiasis. J Clin Immunol. 2021;41(8):1804\u201338.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1228_CR31","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10875-021-01197-y","volume":"42","author":"A Urban","year":"2022","unstructured":"Urban A, Wyndham NLPCMCRMW, Pittaluga S, Irini CWPCTHDNP, Freeman AF. Malignancy in STAT3 deficient hyper IgE syndrome. J Clin Immunol. 2022;42(3):699\u2013702.","journal-title":"J Clin Immunol"},{"key":"1228_CR32","doi-asserted-by":"publisher","first-page":"878989","DOI":"10.3389\/fimmu.2022.878989","volume":"13","author":"L Pietzsch","year":"2022","unstructured":"Pietzsch L, K\u00f6rholz J, Boschann F, Sergon M, Dorjbal B, Yee D, et al. Hyper-IgE and carcinoma in CADINS disease. Front Immunol. 2022;13:878989.","journal-title":"Front Immunol"},{"key":"1228_CR33","doi-asserted-by":"publisher","first-page":"1020927","DOI":"10.3389\/fimmu.2022.1020927","volume":"13","author":"L Urdinez","year":"2022","unstructured":"Urdinez L, Erra L, Palma AM, Mercogliano MF, Fernandez JB, Prieto E, et al. Expanding spectrum, intrafamilial diversity, and therapeutic challenges from 15 patients with heterozygous CARD11-associated diseases: a single center experience. Front Immunol. 2022;13:1020927.","journal-title":"Front Immunol"},{"key":"1228_CR34","doi-asserted-by":"crossref","unstructured":"Aliyath A, Eni-Olotu A, Donaldson N, Trivedi P. Malignancy-associated immune responses: lessons from human inborn errors of immunity. Immunology. 2023.","DOI":"10.1111\/imm.13675"},{"key":"1228_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cyto.2017.03.018","volume":"98","author":"L Avalle","year":"2017","unstructured":"Avalle L, Camporeale A, Camperi A, Poli V. STAT3 in cancer: a double edged sword. Cytokine. 2017;98:42\u201350.","journal-title":"Cytokine"},{"issue":"1","key":"1228_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1749-6632.2011.06295.x","volume":"1246","author":"HC Su","year":"2011","unstructured":"Su HC, Jing H, Zhang Q. DOCK8 deficiency. Ann NY Acad Sci. 2011;1246(1):26\u201333.","journal-title":"Ann NY Acad Sci"},{"issue":"5","key":"1228_CR37","doi-asserted-by":"publisher","first-page":"e13699","DOI":"10.1111\/petr.13699","volume":"24","author":"C Oikonomopoulou","year":"2020","unstructured":"Oikonomopoulou C, Goussetis E. Autosomal dominant hyper-IgE syndrome: when hematopoietic stem cell transplantation should be considered? Pediatr Transpl. 2020;24(5):e13699.","journal-title":"Pediatr Transpl"},{"issue":"4","key":"1228_CR38","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","volume":"91","author":"MO Chandesris","year":"2012","unstructured":"Chandesris MO, Melki I, Natividad A, Puel A, Fieschi C, Yun L, et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine (Baltimore). 2012;91(4):e1\u201319.","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"1228_CR39","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1080\/10428190400004463","volume":"45","author":"G Leonard","year":"2004","unstructured":"Leonard G, Posadas E, Herrmann P, Anderson V, Jaffe E, Holland S, et al. Non-Hodgkin\u2019s lymphoma in Job\u2019s syndrome: a case report and literature review. Leuk Lymphoma. 2004;45(12):2521\u20135.","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"1228_CR40","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1080\/1744666X.2019.1658523","volume":"15","author":"F Kiaee","year":"2019","unstructured":"Kiaee F, Azizi G, Rafiemanesh H, Zainaldain H, Sadaat Rizvi F, Alizadeh M, et al. Malignancy in common variable immunodeficiency: a systematic review and meta-analysis. Expert Rev Clin Immunol. 2019;15(10):1105\u201313.","journal-title":"Expert Rev Clin Immunol"},{"key":"1228_CR41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1155\/2010\/580197","volume":"29","author":"AF Freeman","year":"2010","unstructured":"Freeman AF, Holland SM. Clinical manifestations of hyper IgE syndromes. Dis Mark. 2010;29:123\u201330.","journal-title":"Dis Mark"},{"issue":"6","key":"1228_CR42","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jaci.2011.02.047","volume":"127","author":"N Rezaei","year":"2011","unstructured":"Rezaei N, Hedayat M, Aghamohammadi A, Nichols KE. Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. J Allergy Clin Immunol. 2011;127(6):1329-41. e4.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01228-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01228-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01228-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T11:28:22Z","timestamp":1702726102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01228-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,4]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1228"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01228-5","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,4]]},"assertion":[{"value":"5 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Ethical Committee at the Alborz University of Medical Sciences approved this project (Ethical number:\nIR.ABZUMS.REC.1400.193).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}